New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 14, 2014
20:25 EDTKO, KO, SCHW, SCHW, NTRS, NTRS, CMA, CMA, WABC, WABC, CNSI, CNSI, PBY, PBY, JNJ, JNJNotable companies reporting before tomorrow's open
Notable companies reporting before tomorrow's market open, with earnings consensus, include Johnson & Johnson (JNJ), consensus $1.48; Coca-Cola (KO), consensus 44c; Charles Schwab (SCHW), consensus 22c; Northern Trust (NTRS), consensus 78c; Comerica (CMA), consensus 72c; Westamerica (WABC), consensus 58c; Comverse (CNSI), consensus 49c; Pep Boys (PBY), consensus 5c.
News For JNJ;KO;SCHW;NTRS;CMA;WABC;CNSI;PBY From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | all recent news | >>
January 15, 2015
07:06 EDTJNJJohnson & Johnson downgraded at Goldman
Subscribe for More Information
06:44 EDTJNJJohnson & Johnson downgraded to Sell from Neutral at Goldman
January 14, 2015
15:27 EDTSCHWNotable companies reporting before tomorrow's open
Notable companies reporting before tomorrow's market open, with earnings consensus, include Citigroup (C), consensus 11c; Bank of America (BAC), consensus 32c; Charles Schwab (SCHW), consensus 24c; Fastenal (FAST), consensus 39c.
09:54 EDTKOMcDonald's slips after Ackman says rumored investment 'unlikely'
Subscribe for More Information
09:51 EDTJNJJohnson & Johnson unit says study shows consistent Xarelto safety
Johnson & Johnson unit Janssen announced that a new post-marketing study evaluating the safety of once-daily Xarelto shows, in patients with non-valvular atrial fibrillation, rates and patterns of major bleeding in routine clinical practice are generally consistent with those observed in Phase 3 clinical trials used to approve the medicine for this indication. The fifteen-month results, published today in Clinical Cardiology, represent initial findings from an ongoing, five-year, observational study of patients using Xarelto daily over the course of their lives.
09:46 EDTKOAckman says 'unlikely' to invest in McDonald's, Bloomberg reports
Subscribe for More Information
09:36 EDTSCHWActive equity options trading
Subscribe for More Information
08:50 EDTKOMonster Beverage upgraded to Outperform at Cowen
Subscribe for More Information
January 13, 2015
16:00 EDTJNJOptions Update; January 13, 2015
iPath S&P 500 VIX Short-Term Futures up 66c to 34.42. Option volume leaders: AAPL JNJ CELG WFM TSLA TWTR AMZN GILD according to Track Data.
10:16 EDTKOMonster Beverage rises as Stifel target hike outweighs Wells Fargo downgrade
Subscribe for More Information
10:00 EDTJNJJanssen Biotech announces license agreement with Vedanta Biosciences
Subscribe for More Information
10:00 EDTCMAOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
07:45 EDTJNJFierce Biotech to hold a breakfast meeting
Subscribe for More Information
07:13 EDTKOMonster Beverage price target raised to $130 from $115 at Stifel
Subscribe for More Information
06:41 EDTCMAComerica upgraded to Neutral from Underperform at RW Baird
Subscribe for More Information
January 12, 2015
16:58 EDTKOCoca-Cola shares look expensive, Barron's says
Coca-Cola shares look expensive, trading at over 21 times forward earnings, Barron's argues in a follow up article. Reference Link
10:34 EDTKOFood makers slip as Citi highlights headwinds with downgrades in space
Subscribe for More Information
08:37 EDTJNJShire deal suggests most biotech companies in play, says JMP Securities
After Shire (SHPG) agreed to buy NPS Pharmaceuticals (NPSP), JMP Securities says the deal indicates that most biotech companies are in play, particularly those with worldwide rights to their products for well-defined patient populations. The firm expects investors to speculate all week about potential new targets in the space. Publicly traded companies in the space include AstraZeneca (AZN), Bristol-Myers (BMY), Eli Lilly (LLY), GlaxoSmithKline (GSK), Johnson & Johnson (JNJ), Merck (MRK), Novartis (NVS), Pfizer (PFE), Roche (RHHBY) and Sanofi (SNY).
07:21 EDTJNJEBD Group to hold a conference
Subscribe for More Information
06:52 EDTCMAAnalyst says oil price decline to hurt banks, NY Times reports
As a result of the decline in oil prices, banks in energy producing states will at least suffer a loan growth slowdown and may also see some defaults, Charles Peabody, a banking specialist at Portales Partners said, according to The New York Times. Banks that could be significantly affected by low oil prices include BOK Financial (BOKF) Cullen/Frost (CF), Zions Bancorporation (ZION) , Prosperity Bancshares (PB) 7%, and Comerica (CMA) 7%, BMO Capital stated last December 1. Reference Link
1 | 2 | 3 | 4 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use